{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:37:29Z","timestamp":1763116649777,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24CA208132","U01CA195568"],"award-info":[{"award-number":["K24CA208132","U01CA195568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006399","name":"Spectrum Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006939","name":"Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013252","name":"TG Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.clml.2019.06.009","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T22:40:54Z","timestamp":1561502454000},"page":"699-708.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region"],"prefix":"10.1016","volume":"19","author":[{"given":"Amy A.","family":"Ayers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylin","family":"Dance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean L.","family":"Koff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren E.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.06.009_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2019.06.009_bib2","first-page":"443","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2019.06.009_bib3","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1055-9965.EPI-12-0466","article-title":"Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States","volume":"21","author":"Flowers","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clml.2019.06.009_bib4","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2014-04-568766","article-title":"Socioeconomic disparities in lymphoma","volume":"123","author":"Flowers","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.06.009_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2018-03-839035","article-title":"Disparities in survival by insurance status in follicular lymphoma","volume":"132","author":"Goldstein","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.06.009_bib6","first-page":"551","article-title":"Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors","volume":"29","author":"Keegan","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2019.06.009_bib7","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1002\/cncr.27513","article-title":"Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study","volume":"118","author":"Nabhan","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.06.009_bib8","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1080\/10428194.2018.1546855","article-title":"Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study","volume":"60","author":"Ritter","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.06.009_bib9","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.25765","article-title":"Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States","volume":"117","author":"Shenoy","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.06.009_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clml.2011.07.002","article-title":"Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States","volume":"11","author":"Shenoy","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2019.06.009_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clml.2018.12.019","article-title":"Assessing the effectiveness of treatment sequences for older patients with high-risk follicular lymphoma with a multistate model","volume":"19","author":"Caglayan","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2019.06.009_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/10428194.2015.1083098","article-title":"Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma","volume":"57","author":"Chen","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.06.009_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.currproblcancer.2007.01.005","article-title":"Racial differences in the incidence and outcomes for patients with hematological malignancies","volume":"31","author":"Flowers","year":"2007","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.clml.2019.06.009_bib14","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/cncr.28083","article-title":"Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma","volume":"119","author":"Bulka","year":"2013","journal-title":"Cancer"},{"volume":"Vol. 2019","year":"2019","author":"United States Census Bureau","key":"10.1016\/j.clml.2019.06.009_bib15"},{"year":"2015","series-title":"SEER Cancer Statistics Review, 1975-2012","author":"Howlader","key":"10.1016\/j.clml.2019.06.009_bib16"},{"key":"10.1016\/j.clml.2019.06.009_bib17","series-title":"National Cancer Institute, Surveillance Research Program ed. Vol. released April 2018, based on the November 2017 submission","article-title":"SEER*Stat Database: Incidence - SEER 18 Regs Research Data\u00a0+ Hurricane Katrina Impacted Louisiana Cases, Nov 2017 Sub (1973-2015 varying) - Linked To County Attributes - Total U.S., 1969-2016 Counties","author":"Surveillance E, and End Results (SEER) Program","year":"2018"},{"key":"10.1016\/j.clml.2019.06.009_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canep.2016.01.008","article-title":"Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma","volume":"41","author":"Switchenko","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clml.2019.06.009_bib19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.14423\/SMJ.0000000000000545","article-title":"Relations between residential proximity to EPA-designated toxic release sites and diffuse large B-cell lymphoma incidence","volume":"109","author":"Bulka","year":"2016","journal-title":"South Med J"},{"key":"10.1016\/j.clml.2019.06.009_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/aje\/kwn119","article-title":"Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use","volume":"168","author":"Lee","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clml.2019.06.009_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.06.009_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jncimonographs\/lgu004","article-title":"Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Monnereau","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clml.2019.06.009_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Morton","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clml.2019.06.009_bib24","doi-asserted-by":"crossref","first-page":"e0038","DOI":"10.5041\/RMMJ.10172","article-title":"Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy","volume":"5","author":"Horesh","year":"2014","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.clml.2019.06.009_bib25","doi-asserted-by":"crossref","first-page":"e8135","DOI":"10.1371\/journal.pone.0008135","article-title":"Reproductive factors and non-Hodgkin lymphoma risk in the California Teachers Study","volume":"4","author":"Prescott","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2019.06.009_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial differences in three major NHL subtypes: descriptive epidemiology","volume":"39","author":"Li","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clml.2019.06.009_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jncimonographs\/lgu010","article-title":"Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Cerhan","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clml.2019.06.009_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jncimonographs\/lgu006","article-title":"Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Linet","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clml.2019.06.009_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1586\/14737140.2015.1023712","article-title":"New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy","volume":"15","author":"Chihara","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clml.2019.06.009_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11899-015-0267-0","article-title":"To each its own: linking the biology and epidemiology of NHL subtypes","volume":"10","author":"Koff","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.clml.2019.06.009_bib31","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.2686.2686","article-title":"Racial disparities in cell of origin among DLBCL patients","volume":"120","author":"Flowers","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.06.009_bib32","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/cncr.29526","article-title":"Identifying racial differences in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"121","author":"Flowers","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.06.009_bib33","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/cncr.28233","article-title":"Racial differences in chronic lymphocytic leukemia. Digging deeper","volume":"119","author":"Flowers","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.06.009_bib34","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2013-07-517110","article-title":"Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era","volume":"123","author":"Tao","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.06.009_bib35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ajh.20968","article-title":"Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group","volume":"82","author":"Yamauchi","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.06.009_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1309\/AJCP4H6ADGYDZMOA","article-title":"Diffuse large B-cell lymphoma in Chinese patients: immunophenotypic and cytogenetic analyses of 124 cases","volume":"133","author":"Chen","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.06.009_bib37","first-page":"68","article-title":"New challenges in the management of diffuse large B-cell lymphoma","volume":"2","author":"Flowers","year":"2012","journal-title":"Treat Strateg Hematol"},{"key":"10.1016\/j.clml.2019.06.009_bib38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1440-1827.2008.02273.x","article-title":"Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia","volume":"58","author":"Peh","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.clml.2019.06.009_bib39","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/jcp.2004.022624","article-title":"High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients","volume":"58","author":"Shia","year":"2005","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clml.2019.06.009_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1179\/102453309X385205","article-title":"Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma","volume":"14","author":"Alacacioglu","year":"2009","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2019.06.009_bib41","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2019.06.009_bib42","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1038\/s41467-018-06354-3","article-title":"Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma","volume":"9","author":"Arthur","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.clml.2019.06.009_bib43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.clml.2019.06.009_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.clml.2019.06.009_bib45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clml.2019.06.009_bib46","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ajh.23708","article-title":"The impact of race, age, and sex in follicular lymphoma: a comprehensive SEER analysis across consecutive treatment eras","volume":"89","author":"Nabhan","year":"2014","journal-title":"Am J Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019302800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019302800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:32:57Z","timestamp":1761870777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265019302800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2152265019302800"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.06.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}